MAPT and Alzheimer disease: While AD is neuropathologically diagnosed through postmortem assessments in patients with dementia31, recent research framework has established antemortem AD classification using biomarkers for Aβ deposition (A), pathologic tau (T), and neurodegeneration (N)32.